Abstract
Hyperkalemia in patients on dialysis is associated with an increased mortality rate. Dietary restriction is often not effective and deprives patients of heart-healthy foods. Lowering the dialysate K+ concentration can potentially increase the risk of arrhythmias. In this commentary, we discuss the findings of Amdur et al., and the potential use for K+-binding drugs as a strategy to maintain plasma K+ concentrations within a narrow and normal range during the interdialytic and intradialytic intervals.
Original language | English (US) |
---|---|
Pages (from-to) | 1095-1097 |
Number of pages | 3 |
Journal | Kidney international |
Volume | 98 |
Issue number | 5 |
DOIs |
|
State | Published - Nov 2020 |
ASJC Scopus subject areas
- Nephrology